PuraPharm Corp. Ltd. (1498) Financial Statements

0 Followers

PuraPharm Corp. Ltd. Financial Overview

PuraPharm Corp. Ltd.'s market cap is currently HK$160.48M. The company's EPS TTM is HK$-0.0903; its P/E ratio is -4.22; PuraPharm Corp. Ltd. is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 336.11M	HK$ 382.09M	HK$ 406.86M	HK$ 448.07M	HK$ 659.59M
Gross Profit	HK$ 180.16M	HK$ 205.14M	HK$ 216.63M	HK$ 260.59M	HK$ 421.85M
Operating Income	HK$ -29.98M	HK$ -29.41M	HK$ -51.58M	HK$ -64.50M	HK$ 17.62M
EBITDA	HK$ 6.23M	HK$ 17.35M	HK$ -26.31M	HK$ -46.34M	HK$ -40.03M
Net Income	HK$ -35.22M	HK$ -35.44M	HK$ -106.08M	HK$ -120.21M	HK$ -121.88M
Balance Sheet
Cash & Short-Term Investments	HK$ 21.18M	HK$ 12.79M	HK$ 47.22M	HK$ 91.36M	HK$ 85.05M
Total Assets	HK$ 693.76M	HK$ 715.73M	HK$ 843.96M	HK$ 1.02B	HK$ 1.21B
Total Debt	HK$ 351.14M	HK$ 363.76M	HK$ 424.77M	HK$ 503.16M	HK$ 531.96M
Net Debt	HK$ 329.97M	HK$ 350.96M	HK$ 404.64M	HK$ 396.14M	HK$ 446.90M
Total Liabilities	HK$ 560.59M	HK$ 604.53M	HK$ 690.73M	HK$ 757.18M	HK$ 803.13M
Stockholders' Equity	HK$ 130.48M	HK$ 111.20M	HK$ 153.24M	HK$ 258.29M	HK$ 401.56M
Cash Flow
Free Cash Flow	HK$ 25.69M	HK$ 89.18M	HK$ 57.95M	HK$ 42.29M	HK$ -45.89M
Operating Cash Flow	HK$ 28.52M	HK$ 103.98M	HK$ 79.61M	HK$ 65.85M	HK$ -39.33M
Investing Cash Flow	HK$ 24.12M	HK$ -11.71M	HK$ -18.20M	HK$ -25.45M	HK$ 6.00M
Financing Cash Flow	HK$ -46.34M	HK$ -86.43M	HK$ -122.39M	HK$ -12.94M	HK$ -13.87M

Currency in HKD

PuraPharm Corp. Ltd. Earnings and Revenue History

Income Statement >

PuraPharm Corp. Ltd. Debt to Assets

Balance Sheet >

PuraPharm Corp. Ltd. Cash Flow

Cash Flow >

PuraPharm Corp. Ltd. Forecast EPS vs Actual EPS

Earnings >